Cancer Cause and Prevention Research in Texas
Cancer Cause and Prevention Research (93.393) awarded $259 million to recipients in Texas in 205 grants from fiscal 2021 to 2025, 7.2% of the program's national total. The Univeristy of Texas M.D. Anderson Cancer Center received the most, $107 million.
- Awarded in Texas$259 million
- Awards205
- Share of the program7.2%
- Rank among states4th of 48
- National total$3.6 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 101 | $45.2 million |
| FY 2022 | 109 | $50.9 million |
| FY 2023 | 114 | $52.7 million |
| FY 2024 | 107 | $54.6 million |
| FY 2025 | 95 | $56.0 million |
Recipients in Texas
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| The Univeristy of Texas M.D. Anderson Cancer Center | Colleges and universities | 81 | $107 million |
| Baylor College of Medicine | Colleges and universities | 32 | $49.8 million |
| The University of Texas Southwestern Medical Center | Colleges and universities | 31 | $35.0 million |
| The University of Texas Health Science Center at San Antonio | Colleges and universities | 13 | $21.8 million |
| University of Texas Health Science Center at Houston | Colleges and universities | 12 | $16.2 million |
| University of Texas at Austin | Colleges and universities | 7 | $9.6 million |
| The Methodist Hospital Research Institute | Nonprofits | 6 | $4.6 million |
| Texas A&m Agrilife Research | Colleges and universities | 3 | $4.3 million |
| Texas a & M University System Health Science Center | Colleges and universities | 2 | $2.8 million |
| William Marsh Rice University | Colleges and universities | 3 | $2.2 million |
Open opportunities under this program
- Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
- Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)
- National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
- Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional)
- Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed)
- HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)
- Carcinogen Hazard Assessment Monographs Program (CHAMP) (R01 Clinical Trial Not Allowed)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
- NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
See all 58 on the program page
Questions people ask
How much Cancer Cause and Prevention Research money goes to Texas?
$259 million from fiscal 2021 to 2025, across 205 awards. Texas ranks 4th of 48 states and territories for this program.
Who receives Cancer Cause and Prevention Research money in Texas?
The largest recipient is The Univeristy of Texas M.D. Anderson Cancer Center, with $107 million in 81 awards. Next are Baylor College of Medicine and The University of Texas Southwestern Medical Center.
Can organizations in Texas apply now?
Yes, 58 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Cancer Cause and Prevention Research in other states
Other large programs in Texas
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- National School Lunch Program
- Disaster Grants - Public Assistance (Presidentially Declared Disasters)
- Child Care and Development Block Grant
- Title I Grants to Local Educational Agencies
- Unaccompanied Alien Children Program
- Special Education Grants to States
- Community Development Block Grants/State's program and Non-Entitlement Grants in Hawaii